Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Johnson & Johnson gains on talc litigation update; analyst reactions positive

Published 04/04/2023, 04:29 PM
Updated 04/05/2023, 06:51 AM
© Reuters.
JNJ
-

By Yasin Ebrahim and Senad Karaahmetovic

Investing.com -- Johnson & Johnson (NYSE:JNJ) said Wednesday its subsidiary LTL Management has re-filed for Chapter 11 bankruptcy protection just months after an appeals court rejected its "Texas two-step" process to settle lawsuits that allege its talc products caused cancer.

Shares of the company are up over 3% in pre-market Wednesday.

Chapter 11 is needed to move ahead with a reorganization plan that includes a commitment to pay up to a present value of $8.9 billion, over 25 years, to settle all current and future talc claims, J&J said. The amount represents an increase of $6.9B over the $2B previously committed related to LTL's initial bankruptcy filing in October 2021, the company said. More than 60,000 current claimants support a global resolution on these terms, it added.

Johnson and Johnson created a subsidiary LTL Management and placed it into bankruptcy --  a Texas two-step strategy -- to deal with tens of thousands of legal claims alleging its talc caused cancer. But earlier this year in January, a U.S. appeals court dismissed the Chapter 11 petition filed as the subsidiary wasn't in financial distress.

The company reiterated that "neither LTL's original filing nor this re-filing is an admission of wrongdoing, nor an indication that the company has changed its longstanding position that its talcum powder products are safe."

Bank of America analysts said the news is encouraging, however, the final outcome is still uncertain.

"It’s unclear to us at this time whether the current proposal will ultimately be accepted by the court and claimants given a much higher anticipated value above the $10B range, according to the court filings."

Morgan Stanley analysts believe this development is "an incremental positive for the stock."

"At this point we don't see the litigation as a material risk to the company, but we've noted that it is likely to remain an overhang on the stock given the range of potential outcomes. JNJ has a strong balance sheet ($24bn cash as of 4Q22)," they wrote in a note.

 
 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.